GEMTUZUMABUM OZOGAMICINUM – vedlejsiucinky.cz
(CA)
GEMTUZUMAB OZOGAMICIN(INNE)
GEMTUZUMAB OZOGAMICINE(INNF)
GEMTUZUMAB OZOGAMICINA(INNS)
GEMTUZUMAB OZOGAMICIN(SLE)
GEMTUZUMAB OZOGAMICIN(INNC)
IMMUNOGLOBULIN G4-KAPPA, ANTI-[HOMO SAPIENS CD33 (SIALIC ACID BINDING IG-LIKE LECTIN 3,SIGLEC3, SIGLEC-3,GP67, P67)], HUMANIZED MONOCLONAL ANTIBODY CONJUGATED TO N-ACETYL-GAMMA CALICHEAMICIN; GAMMA4 HEAVY CHAIN (1-443) [HUMANIZED VH (HOMO SAPIENS IGHV1-3*01 (72.90%) -(IGHD) -IGHJ5*01) [8.8.9] (1-116)), IGHG4*01 (CH1 (117-214), HINGE S10>P (224) (215-226), CH2 (227-336), CH3 (337-441), CHS (442- 443)) (117-443)], (130-218')-DISULFIDE WITH KAPPA LIGHT CHAIN (1'-218') [HUMANIZED V-KAPPA (HOMO SAPIENS IGKV1- 5*01 (81.90%) -IGKJ1*01) [10.3.9] (1'-111') -HOMO SAPIENS IGKC*01, KM3 (112'-218')]; DIMER (232-232":235-235")- BISDISULFIDE; CONJUGATED, ON AN AVERAGE OF 2 OR 3 LYSYL (0-6), TO N-ACETYL-S'-DES(METHYLSULFANYL)-S'-(4-HYDRAZINYL-2- METHYL-4-OXOBUTAN-2-YL)CALICHEAMICIN GAMMA1 VIA A BIFUNCTIONAL 4-(4-ACETYLPHENOXY)BUTANOYLE (ACBUT) LINKER, RECOMMENDED INN: LIST 77(WHO)
GEMTUZUMABUM OZOGAMICINUM(INN)